PURPOSE Acute respiratory distress syndrome is a life-threatening form of respiratory failure without an established pharmacological treatment. Recently, macrolides have been found to be beneficial in cases of acute lung injury, but evidence is limited. MATERIALS AND METHODS This single-centre retrospective cohort evaluation of hospitalized patients with sepsis-associated acute respiratory di...

Surfactant-replacement therapy is a life-saving treatment for preterm infants with respiratory distress syndrome, a disorder characterized by surfactant deficiency. Repletion with exogenous surfactant decreases mortality and thoracic air leaks and is a standard practice in the developed world. In addition to respiratory distress syndrome, other neonatal respiratory disorders are characterized b...

OBJECTIVE To review the current support and treatment strategies of the acute respiratory distress syndrome. DATA SOURCES Original data from our research laboratory and from representative scientific articles on acute respiratory distress syndrome and acute lung Injury searched through Medline. SUMMARY OF THE FINDINGS Despite advances in the understanding of the pathogenesis of acute respir...

OBJECTIVES Platelet activation plays an active role in the pathogenesis of acute respiratory distress syndrome. In our prior study of 575 patients at high risk for acute respiratory distress syndrome, concurrent statin and aspirin use was associated with reduced acute respiratory distress syndrome. However, the largest study (n = 3,855) to date found no significant benefit of prehospital aspiri...

The acute respiratory distress syndrome (ARDS) is a serious and complex clinical problem that often threatens the lives of patients. Emerging clinical data suggest that the survival of patients with this disorder may have improved during the last two decades, presumably because of advances in supportive medical care. Among the supportive therapies used to treat patients with ARDS, none is more ...

Respiratory distress syndrome (RDS) is seen primarily in the preterm neonate and is due mostly to pulmonary surfactant deficiency. Lung atelectasis leads to ventilationperfusion mismatching, hypoxia, and eventual respiratory failure in the untreated infant who has RDS. RDS is diagnosed by physical findings consistent with respiratory distress and characteristic radiographic findings. Treatment ...

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) is a clinical condition characterized by impaired gas exchange as a result of the accumulation of edema in the alveolar space. The clinical management of ARDS patients includes mechanical ventilation with high oxygen concentrations. Mechanical ventilation alleviates the work of breathing and hypoxemia while allowing time for the lungs to recover from t...

VALID AND RELIABLE DEFINItions are essential to conduct epidemiological studies successful ly and to facilitate enrollment of a consistent patient phenotype into clinical trials. Clinicians also need such definitions to implement the results of clinical trials, discuss prognosis with families, and plan resource allocation. Following the initial description of acute respiratory distress syndrome...

ACCP Critical Care Board Review 2003 T acute respiratory distress syndrome (ARDS) and the related acute lung injury (ALI) syndromes are forms of Type I or acute hypoxemic respiratory failure (AHRF). This form of lung dysfunction rises from diseases causing collapse and/or filling of alveoli with the result that a substantial fraction of mixed venous blood traverses nonventilated airspaces, effe...

INTRODUCTION Acute respiratory distress syndrome (ARDS) is characterised by lung inflammation with severe hypoxia, which usually develops over 4-48 hours and persists for days or weeks. The main causes of ARDS are infections, aspiration of gastric contents, and trauma. Between a third and a half of people with ARDS die from the disease, but mortality depends on the underlying cause. Some surviv...